Phylex BioSciences demonstrates power of AI-derived mRNA nanoparticle vaccine technology by designing ready-to-manufacture Andes hantavirus vaccine in two days
May 13, 2026
DEL MAR, California – May 13, 2026 – Phylex Biosciences announces the first research project to develop... Read More
Phylex Biosciences set to develop AI-derived mRNA nanoparticle vaccine against Metapneumovirus
March 12, 2026
New vaccine to combat growing threat in California
DEL MAR, California – March 12, 2026 – Phylex... Read More
Phylex BioSciences Publishes in Scientific Journal “Vaccine” Superior Immunogenicity Results in the Field of Nipah mRNA Vaccines
July 23, 2025
DEL MAR, California – July 23, 2025 – Phylex Biosciences has published in the peer-reviewed scientific... Read More
Phylex Vaccine on Track to Combat Deadly Nipah Virus with Positive Results of Immunogenicity Study
August 6, 2024
DEL MAR, California – August 6, 2024 – Phylex BioSciences has achieved positive results with its new mRNA... Read More
Phylex BioSciences Announces Nipah Virus Vaccine Initiative with its Nanoparticle mRNA Vaccine Technology
September 22, 2023
DEL MAR, California – September 22, 2023 – Since late August the Indian state of Kerala is experiencing... Read More
Phylex BioSciences Publishes Positive Results of Protection Study Against SARS-CoV-2 Delta Variant with its Second Generation mRNA Vaccine
March 23, 2022
DEL MAR, California – March 23, 2022 – Two years into the COVID-19 pandemic there is still a... Read More
Phylex BioSciences Announces Development of SARS-CoV-2 Delta and Omicron Bivalent Vaccine for 2022
December 6, 2021
DEL MAR, California – December 6, 2021 – The new omicron variant is a game changer as current vaccine... Read More
New Variant in France Highlights the Challenge for Current Vaccines
April 1, 2021
DEL MAR, California – April 1, 2021 – French virologists in hospital Henri Mondor near Paris reported... Read More
New UK and South Africa Variants Confirm Need for Universal SARS Coronavirus Vaccine
December 28, 2020
DEL MAR, California – December 28, 2020 – Two weeks ago the UK reported a new variant of the SARS-CoV-2... Read More